Engineered probiotic alleviates ulcerative colitis by inhibiting M1 macrophage polarization via glycolytic reprogramming.

Saved in:
Bibliographic Details
Title: Engineered probiotic alleviates ulcerative colitis by inhibiting M1 macrophage polarization via glycolytic reprogramming.
Authors: Lv, Chaoqun1 (AUTHOR), Hu, Xinyue1 (AUTHOR), Li, Xiang1 (AUTHOR), Shi, Wen1 (AUTHOR), Li, Wenbo1 (AUTHOR), He, Yan1 (AUTHOR), Li, Hongqing2 (AUTHOR), Bai, Jianxi1 (AUTHOR), Li, Zhenxing1 (AUTHOR), Wen, Zhipeng1 (AUTHOR), Liu, Xinxin1 (AUTHOR), Ai, Yuanyuan1 (AUTHOR), Li, Jingchao2 (AUTHOR), Chen, Xiao2 (AUTHOR) xiaochen229@tmmu.edu.cn, Liu, Kaijun1 (AUTHOR) kliu@tmmu.edu.cn
Source: Bioengineering & Translational Medicine. Nov2025, Vol. 10 Issue 6, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23806761
DOI:10.1002/btm2.70067